Safety and efficacy of JWATM204, a novel Glypican-3 (GPC3)-targeted CAR T cell therapy for advanced hepatocellular carcinoma: A phase I dose-escalation study
Safety and efficacy of JWATM204, a novel Glypican-3 (GPC3)-targeted CAR T cell therapy for advanced hepatocellular carcinoma: A phase I dose-escalation study
Jing Tang, Gang Wu, Jun Xue, Tao Zhang et al.
Journal
Cancer Pathogenesis and Therapy
Topics
CAR-T cell therapy research
article
Safety and efficacy of JWATM204, a novel Glypican-3 (GPC3)-targeted CAR T cell therapy for advanced hepatocellular carcinoma: A phase I dose-escalation study
Jing Tang, Gang Wu, Jun Xue, Tao Zhang, Zanyi Wu, Jinfeng Zhang, Jun Fan, Yongqiang Yang, Dongen Liu
article en
Abstract
No abstract available for this paper.
Publication Tag
Cancer Pathogenesis and TherapyVol. 4(4)
Institutions
Union Hospital (HK), Huazhong University of Science and Technology (CN)